USP18 establishes the transcriptional and anti-proliferative interferon α/β differential

Biochemical Journal

Volumn 446, Issue 3, 2012, Pages 509-516

  Francois Newton, Veroniqué ^a   Livingstone, Mark ^a   Payelle Brogard, Béatrice ^a   Uzé, Gilles ^b   Pellegrini, Sandra ^a  

^a CNRS   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Apoptosis; Cytokine signalling; Negative feedback; Protease; Ubiquitin specific protease 18 (USP18)

Indexed keywords

BETA INTERFERON; PROTEINASE; RECOMBINANT ALPHA2 INTERFERON; STAT PROTEIN; UBIQUITIN SPECIFIC PROTEASE 18; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE INDUCTION; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

BINDING SITES; CELL PROLIFERATION; ENDOPEPTIDASES; HUMANS; INTERFERON-ALPHA; INTERFERON-BETA; PHOSPHORYLATION; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 84865585154     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20120541     Document Type: Article

References (45)

1. Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R. and Stark, G. R. (2007) Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6, 975-990 (Pubitemid 350201788)
2. Uze, G., Schreiber, G., Piehler, J. and Pellegrini, S. (2007) The receptor of the type I interferon family. Curr. Top. Microbiol. Immunol. 316, 71-95
3. Borden, E. C. and Williams, B. R. (2011) Interferon-stimulated genes and their protein products: what and how? J. Interferon Cytokine Res. 31, 1-4
4. Tamura, T., Yanai, H., Savitsky, D. and Taniguchi, T. (2008) The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535-584 (Pubitemid 351600385)
5. Manry, J., Laval, G., Patin, E., Fornarino, S., Itan, Y., Fumagalli, M., Sironi, M., Tichit, M., Bouchier, C., Casanova, J. L. et al. (2011) Evolutionary genetic dissection of human interferons. J. Exp. Med. 208, 2747-2759
6. Harrison, G. A., McNicol, K. A. and Deane, E. M. (2004) Type I interferon genes from the egg-laying mammal, Tachyglossus aculeatus (short-beaked echidna). Immunol. Cell Biol. 82, 112-118 (Pubitemid 38594639)
7. Coccia, E. M., Severa, M., Giacomini, E., Monneron, D., Remoli, M. E., Julkunen, I., Cella, M., Lande, R. and Uze, G. (2004) Viral infection and Toll-like receptor agonists induce a differential expression of type I and lambda interferons in human plasmacytoid and monocyte-derived dendritic cells. Eur. J. Immunol. 34, 796-805 (Pubitemid 39255927)
8. Gough, D. J., Messina, N. L., Clarke, C. J., Johnstone, R. W. and Levy, D. E. (2012) Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity 36, 166-174
9. Croze, E., Russell-Harde, D., Wagner, T. C., Pu, H., Pfeffer, L. M. and Perez, H. D. (1996) The human type I interferon receptor. Identification of the interferon β-specific receptor-associated phosphoprotein. J. Biol. Chem. 271, 33165-33168 (Pubitemid 27010335)
10. Runkel, L., Pfeffer, L., Lewerenz, M., Monneron, D., Yang, C. H., Murti, A., Pellegrini, S., Goelz, S., Uze, G. and Mogensen, K. (1998) Differences in activity between α and β type I interferons explored by mutational analysis. J. Biol. Chem. 273, 8003-8008 (Pubitemid 28168850)
11. Domanski, P., Nadeau, O. W., Platanias, L. C., Fish, E., Kellum, M., Pitha, P. and Colamonici, O. R. (1998) Differential use of the βL subunit of the type I interferon (IFN) receptor determines signaling specificity for IFNβ2 and IFNβ. J. Biol. Chem. 273, 3144-3147 (Pubitemid 28109720)
12. Rosenblum, M. G., Yung, W. K., Kelleher, P. J., Ruzicka, F., Steck, P. A. and Borden, E. C. (1990) Growth inhibitory effects of interferon-β but not interferon-α on human glioma cells: correlation of receptor binding, 2′,5′-oligoadenylate synthetase and protein kinase activity. J. Interferon Res. 10, 141-151 (Pubitemid 20138707)
13. Thomas, C., Moraga, I., Levin, D., Krutzik, P. O., Podoplelova, Y., Trejo, A., Lee, C., Yarden, G., Vleck, S. E., Glenn, J. S. et al. (2011) Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell 146, 621-632
14. Marijanovic, Z., Ragimbeau, J., van der Heyden, J., Uze, G. and Pellegrini, S. (2007) Comparable potency of IFNα2 and IFNβ on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Biochem. J. 407, 141-151 (Pubitemid 47535589)
15. Jaitin, D. A., Roisman, L. C., Jaks, E., Gavutis, M., Piehler, J., Van der Heyden, J., Uze, G. and Schreiber, G. (2006) Inquiring into the differential action of interferons (IFNs): an IFN-α2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-β. Mol. Cell. Biol. 26, 1888-1897
16. Marijanovic, Z., Ragimbeau, J., Kumar, K. G., Fuchs, S. Y. and Pellegrini, S. (2006) TYK2 activity promotes ligand-induced IFNAR1 proteolysis. Biochem. J. 397, 31-38 (Pubitemid 44032833)
17. Zheng, H., Qian, J., Varghese, B., Baker, D. P. and Fuchs, S. (2011) Ligand-stimulated downregulation of the α interferon receptor: role of protein kinase D2. Mol. Cell. Biol. 31, 710-720
18. Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J. and Zhang, D. E. (2002) UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J. Biol. Chem. 277, 9976-9981 (Pubitemid 34968105)
19. Malakhova, O. A., Kim, K. I., Luo, J. K., Zou, W., Kumar, K. G., Fuchs, S. Y., Shuai, K. and Zhang, D. E. (2006) UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity. EMBO J. 25, 2358-2367 (Pubitemid 44012219)
20. Moraga, I., Harari, D., Schreiber, G., Uze, G. and Pellegrini, S. (2009) Receptor density is key to the α2/β interferon differential activities. Mol. Cell. Biol. 29, 4778-4787
21. Uze, G. and Monneron, D. (2007) IL-28 and IL-29: newcomers to the interferon family. Biochimie 89, 729-734 (Pubitemid 47001631)
22. Francois-Newton, V., Magno de Freitas Almeida, G., Payelle-Brogard, B., Monneron, D., Pichard-Garcia, L., Piehler, J., Pellegrini, S. and Uze, G. (2011) USP18-based negative feedback control is induced by type I and type III interferons and specifically inactivates interferon α response. PLoS ONE 6, e22200
23. Terenzi, F., White, C., Pal, S., Williams, B. R. and Sen, G. C. (2007) Tissue-specific and inducer-specific differential induction of ISG56 and ISG54 in mice. J. Virol. 81, 8656-8665 (Pubitemid 47242839)
24. Marie, I., Galabru, J., Svab, J. and Hovanessian, A. G. (1989) Preparation and characterization of polyclonal antibodies specific for the 69 and 100 k-dalton forms of human 2-5A synthetase. Biochem. Biophys. Res. Commun. 160, 580-587
25. Flohr, F., Schneider-Schaulies, S., Haller, O. and Kochs, G. (1999) The central interactive region of human MxA GTPase is involved in GTPase activation and interaction with viral target structures. FEBS Lett. 463, 24-28 (Pubitemid 30001711)
26. Lecoeur, H., de Oliveira-Pinto, L. M. and Gougeon, M. L. (2002) Multiparametric flow cytometric analysis of biochemical and functional events associated with apoptosis and oncosis using the 7-aminoactinomycin D assay. J. Immunol. Methods 265, 81-96 (Pubitemid 34632687)
27. Kayagaki, N., Yamaguchi, N., Nakayama, M., Eto, H., Okumura, K. and Yagita, H. (1999) Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: a novel mechanism for the antitumor effects of type I IFNs. J. Exp. Med. 189, 1451-1460 (Pubitemid 29227531)
28. Chawla-Sarkar, M., Leaman, D. W. and Borden, E. C. (2001) Preferential induction of apoptosis by interferon (IFN)-β compared with IFN-α 2: correlation with TRAIL/Apo2L induction in melanoma cell lines. Clin. Cancer Res. 7, 1821-1831 (Pubitemid 32708654)
29. Borden, E. C., Hogan, T. F. and Voelkel, J. G. (1982) Comparative antiproliferative activity in vitro of natural interferons α and β for diploid and transformed human cells. Cancer Res. 42, 4948-4953 (Pubitemid 13223128)
30. Jaks, E., Gavutis, M., Uze, G., Martal, J. and Piehler, J. (2007) Differential receptor subunit affinities of type I interferons govern differential signal activation. J. Mol. Biol. 366, 525-539 (Pubitemid 46136210)
31. van Boxel-Dezaire, A. H., Rani, M. R. and Stark, G. R. (2006) Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25, 361-372 (Pubitemid 44354225)
32. Stawowczyk, M., Van Scoy, S., Kumar, K. P. and Reich, N. C. (2011) The interferon stimulated gene 54 promotes apoptosis. J. Biol. Chem. 286, 7257-7266
33. Thyrell, L., Hjortsberg, L., Arulampalam, V., Panaretakis, T., Uhles, S., Dagnell, M., Zhivotovsky, B., Leibiger, I., Grander, D. and Pokrovskaja, K. (2004) Interferon α-induced apoptosis in tumor cells is mediated through the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway. J. Biol. Chem. 279, 24152-24162 (Pubitemid 38725275)
34. Hjortsberg, L., Lindvall, C., Corcoran, M., Arulampalam, V., Chan, D., Thyrell, L., Nordenskjold, M., Grander, D. and Pokrovskaja, K. (2007) Phosphoinositide 3-kinase regulates a subset of interferon-α-stimulated genes. Exp. Cell Res. 313, 404-414 (Pubitemid 46048824)
35. Potu, H., Sgorbissa, A. and Brancolini, C. (2010) Identification of USP18 as an important regulator of the susceptibility to IFN-α and drug-induced apoptosis. Cancer Res. 70, 655-665
36. Papageorgiou, A., Dinney, C. P. and McConkey, D. J. (2007) Interferon-α induces TRAIL expression and cell death via an IRF-1-dependent mechanism in human bladder cancer cells. Cancer Biol. Ther. 6, 872-879 (Pubitemid 351574976)
37. Johnstone, R. W., Frew, A. J. and Smyth, M. J. (2008) The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat. Rev. Cancer 8, 782-798
38. Clarke, N., Jimenez-Lara, A. M., Voltz, E. and Gronemeyer, H. (2004) Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL. EMBO J. 23, 3051-3060 (Pubitemid 39093599)
39. Sanceau, J., Hiscott, J., Delattre, O. and Wietzerbin, J. (2000) IFN-β induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene 19, 3372-3383 (Pubitemid 30479332)
40. da Silva, A. J., Brickelmaier, M., Majeau, G. R., Lukashin, A. V., Peyman, J., Whitty, A. and Hochman, P. S. (2002) Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-α2b vs. IFN-β 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J. Interferon Cytokine Res. 22, 173-188 (Pubitemid 34275485)
41. Rani, M. R., Foster, G. R., Leung, S., Leaman, D., Stark, G. R. and Ransohoff, R. M. (1996) Characterization of β-R1, a gene that is selectively induced by interferon β (IFN-β) compared with IFN-α. J. Biol. Chem. 271, 22878-22884 (Pubitemid 26304738)
42. Coelho, L. F., Magno de Freitas Almeida, G., Mennechet, F. J., Blangy, A. and Uze, G. (2005) Interferon-α and -β differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. Proc. Natl. Acad. Sci. U.S.A. 102, 11917-11922 (Pubitemid 41170825)
43. Honke, N., Shaabani, N., Cadeddu, G., Sorg, U. R., Zhang, D. E., Trilling, M., Klingel, K., Sauter, M., Kandolf, R., Gailus, N. et al. (2012) Enforced viral replication activates adaptive immunity and is essential for the control of a cytopathic virus. Nat. Immunol. 13, 51-57
44. Chen, L., Borozan, I., Feld, J., Sun, J., Tannis, L. L., Coltescu, C., Heathcote, J., Edwards, A. M. and McGilvray, I. D. (2005) Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128, 1437-1444 (Pubitemid 40712193)
45. Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H., Christen, V., Terracciano, L., Filipowicz, W. and Heim, M. H. (2008) Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl. Acad. Sci. U.S.A. 105, 7034-7039 (Pubitemid 351754525)